Since November 2018 clinicians can prescribe cannabis-dependent products for medicinal use (CBPMs), but NHS prescriptions are tightly managed and relatively exceptional. Normal circumstances where CBPMs is likely to be regarded include critical, therapy-resistant epilepsy plus some ache/spasticity disorders — and also then it always demands a specialist clinic marketing consultant https://helpmehigh.com/